brandaireputation.com

Semantic Coherence: EPCLUSA – Signal Evidence & AI Readability

EPCLUSA

(https://epclusa.com) 📸 Data Snapshot: May 30, 2026
Semantic Coherence — The Lens

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Semantic Coherence Homepage promise vs. Sub-page reality.
20 Impact Weight: 20 / 100
100% Reputation

There is zero semantic drift across the analyzed pages. The homepage promise of curing Hep C ‘your way’ is directly supported by sub-pages explaining the regimen’s compatibility with recovery and medication-assisted treatments. The messaging is highly consistent, focusing on the patient’s schedule and lifestyle across all sub-pages, with no contradictions between the ‘Helpful Resources’ and the ‘Why Epclusa’ value propositions.

Semantic Coherence is read from the heading hierarchy first: what each page announces in its H1 and headings, then whether the body actually delivers on it. Below is the structure the engine mapped, followed by the clean text to check for drift between promise and reality.

🏗️ Semantic Structure — heading hierarchy & page identity (the promise the page makes)
HOMEPAGE EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site (https://epclusa.com)
Title

EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site

Meta

Discover EPCLUSA® (sofosbuvir/velpatasvir), a prescription medicine used to treat chronic Hep C. See Important Safety Information including Important Warning.

H2 Treat hepatitis C your way
H4 Find confidence in curing Hep C with EPCLUSA on your To-Day List.
H5 Have Medicaid?
H5 Hep C may lead to serious liver damage.
H5 One pill, once a day, one step closer to cure.
H5 EPCLUSA can treatHep C
H5 Questions about Hep C treatment?
H6 Find confidence in curing Hep C with EPCLUSA on your To-Day List.
H6 Find a healthcare provider
H6 Cure Hep C while in recovery
NAV_HEADER_HEADING_REPEATED_FOOTER Why Treat Hep C Virus With EPCLUSA®? | Patient Site (https://epclusa.com/why-treat-hep-c/)
Title

Why Treat Hep C Virus With EPCLUSA®? | Patient Site

Meta

Learn about the urgency & importance of treating your Hepatitis C. Read how to treat Hep C with EPCLUSA® & Important Safety Information, including Important Warning.

H4 Watch this video to learn more
H4 Quick facts about hepatitis C:
H4 Liver damage over time
H4 Hep C can be cured with EPCLUSA, even in recovery
H5 How many people have Hep C
H5 How Hep C can be spread
H5 Hep C symptoms
H5 Can be taken with many medication-assisted treatments including buprenorphine/naloxone, methadone, and naltrexone
H5 Can be taken whether you're in recovery or not
H5 Works with your schedule
H5 One pill, once a day, for 12 weeks. In a regular pill bottle small enough to fit in your pocket
H6 Find a healthcare provider
H6 Learn more about EPCLUSA side effects
NAV_HEADER_HEADING_REPEATED_FOOTER Why Choose EPCLUSA® as Your Treatment for Hep C | Patient Site (https://epclusa.com/why-epclusa/)
Title

Why Choose EPCLUSA® as Your Treatment for Hep C | Patient Site

Meta

EPCLUSA® (sofosbuvir/velpatasvir) may be a treatment choice for adults living with Chronic Hep C. Read Important Safety Information including Important Warning.

H5 One pill, once a day, one step closer to cure.
H5 Have Medicaid?
H5 Being “ready” to cure Hep C looks different for everyone.
H5 Can be taken with many forms of birth control.†
H5 FDA approved for use in children 3 years of age and older.
H6 Find a healthcare provider
H6 Learn more about EPCLUSA side effects
NAV_HEADER_HEADING_REPEATED_FOOTER EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) Resources | Patient Site (https://epclusa.com/helpful-resources/)
Title

EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) Resources | Patient Site

Meta

Find downloadable resources to help you speak to a healthcare provider. Watch the EPCLUSA® (sofosbuvir/velpatasvir) Hep C commercial to learn more. Read Important Safety Information Including Important Warning.

H5 EPCLUSA Patient Brochure
H5 EPCLUSA Patient Starter Kit
H5 Caregiver Booklet
H5 EPCLUSA Patient Brochure – Spanish
H5 EPCLUSA Patient Starter Kit – Spanish
H5 Financial Resources
📝 The Narrative — clean text per page (homepage promise vs. sub-page reality)
HOMEPAGE · THIN (https://epclusa.com) EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site 

                        
0 chars

                    

                                    

                        
                            
                                SUB-PAGE                                 · THIN                            
                            (https://epclusa.com/why-treat-hep-c/)
                            
                                Why Treat Hep C Virus With EPCLUSA®? | Patient Site                            
                        
                        

                        
0 chars

                    

                                    

                        
                            
                                SUB-PAGE                                 · THIN                            
                            (https://epclusa.com/why-epclusa/)
                            
                                Why Choose EPCLUSA® as Your Treatment for Hep C | Patient Site                            
                        
                        

                        
0 chars

                    

                                    

                        
                            
                                SUB-PAGE                                 · THIN                            
                            (https://epclusa.com/helpful-resources/)
                            
                                EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) Resources | Patient Site                            
                        
                        

                        
0 chars

                    

                            

        


    


    

    
    

        Explore the other reputation pillars for EPCLUSA
        

                            
                    Information Density
                    →
                
                            
                    Trust & Proof
                    →
                
                            
                    Commodity Fingerprint
                    →
                
                            
                    Identity & Authority
                    →
                
                    

    


    

    
    

        Analysis Disclosure & Source Attribution
        
This page presents a snapshot of public data from EPCLUSA, captured on May 30, 2026, to show how machine logic reads Semantic Coherence signals into an AI reputation evaluation.

        
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.

        
Notice to EPCLUSA: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.

        
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.

        
To all users: You are encouraged to visit the live site at https://epclusa.com to view the most current version of its content and see directly what this company is about and what it offers.